Related Experiment Videos

Inhibition of sphingolipid synthesis down-modulates CD4 expression by peripheral blood T lymphocytes and T lymphoma

S L Tamma1, S K Sundaram, M Lev

  • 1Department of Microbiology & Immunology, City University of New York Medical School, 10031, USA.

Insights

L-cycloserine, an inhibitor of sphingolipid biosynthesis, selectively reduces CD4 expression on T cells, potentially blocking HIV infection. This suggests a novel therapeutic strategy targeting HIV cell binding and infectivity.

Area of Science:

  • Immunology
  • Virology
  • Biochemistry

Background:

  • Sphingolipids are crucial cellular components.
  • Human Immunodeficiency Virus (HIV) infects CD4+ T cells.
  • L-cycloserine inhibits sphingolipid biosynthesis.

Purpose of the Study:

  • To investigate the mechanism by which L-cycloserine interferes with HIV life cycle.
  • To examine the effect of L-cycloserine on CD4 expression in T cells.

Main Methods:

  • Experiments were conducted using human T cells and CD4+ T lymphoma cells.
  • CD4, CD3, and CD8 expression levels were measured.
  • T cell mitogen responses and IL-2 production were assessed.
  • Membrane lipid composition and microviscosity were analyzed.

Main Results:

  • L-cycloserine selectively down-modulated CD4 expression.
  • CD3 and CD8 expression remained unaffected.
  • T cell mitogen responses were inhibited, but IL-2 production was not.
  • Changes in membrane lipid composition correlated with altered microviscosity.

Conclusions:

  • Normal CD4 expression appears dependent on sphingolipid biosynthesis.
  • L-cycloserine's selective inhibition of CD4 and antiviral effects present a novel approach against HIV.
  • This strategy may interfere with HIV cell binding and infectivity.

Related Concept Videos